C493 - Campfire Session
Viral Hepatitis and BK Post-Transplant

Tuesday July 03, 2018 | 16:30 to 17:30
Room: Hall 10 - Exhibition
Track: Infectious Diseases

Presentations

Dr. Maggie K. M. Ma, Hong Kong
Staged screening of BK virus-associated nephropathy using urine cytology and serum quantitative polymerase chain reaction: Hong Kong experience

Dr. Natalia I Polanco, Spain
The use of sofosbuvir (SOF)-containing direct antiviral agents (DAA)-based regimens requires increase in tacrolimus (Tac) doses in kidney transplant (KT) recipients with hepatitis C virus (HCV) infection

Dr. Mohamad M Alkadi, Qatar
Clinical outcomes of sofosbuvir-based direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus



© 2021 TTS2018